Elsevier

Immunology Letters

Volume 30, Issue 2, October 1991, Pages 241-248
Immunology Letters

Genetic regulation of macrophage priming/activation: the Lsh gene story

https://doi.org/10.1016/0165-2478(91)90032-6Get rights and content

Abstract

This paper describes functional and genetic studies on the macrophage resistance gene Lsh/Ity/Bcg first described almost two decades ago. Working in vitro with resident peritoneal, liver (Kupffer cells) and bone marrow derived macrophages from congenic B10 (LshS) and B10.L-LshR mice it has been possible to demonstrate that the final effector mechanism for the gene in regulating antileishmanial activity involves production of reactive nitrogen rather than reactive oxygen intermediates. This in turn is dependent upon priming/activation of macrophages for enhanced TNF-α release which acts back on the macrophage in an autocrine manner to increase nitric oxide production. The precise point at which Lsh acts to control macrophage priming/activation has not been identified, but studies of early response gene expression show differences in KC mRNA levels at 2 h after LPS stimulation, and in c-fos mRNA as early as 20 min after stimulation with PMA plus ionophore, in peritoneal macrophages from congenic LshS and LshR mice. Data available suggest that both negative and positive signals may be involved in macrophage priming/activation, with LshS macrophages down-regulating their capacity for continued response to the autocrine loop. Work in progress will examine the role of TPA and cAMP response element-binding proteins in regulating gene expression in Lsh congenic mice. A major new initiative has also commenced to clone the Lsh gene by reverse genetics using yeast artificial chromosomes to walk towards Lsh from the closest proximal and distal markers on mouse chromosome 1. Family linkage analysis using restriction fragment length polymorphisms for marker genes on human chromosome 2q has begun to provide some evidence that a human homologue for Lsh may regulate resistance and susceptibility to leprosy and tuberculosis in man.

References (77)

  • J.M. Blackwell

    Res. Immunol.

    (1989)
  • P.M. Kaye et al.

    Res. Immunol.

    (1989)
  • J.M. Blackwell et al.

    Res. Immunol.

    (1989)
  • I.M. Verma et al.

    Cell

    (1987)
  • S.L. Pelech et al.

    Trends Biochem. Sci.

    (1989)
  • T. Hunter

    Cell

    (1991)
  • J-X. Lin et al.

    J. Biol. Chem.

    (1987)
  • B. Mock et al.

    Genomics

    (1990)
  • E. Schurr et al.

    Genomics

    (1990)
  • D. Malo et al.

    Genomics

    (1991)
  • A.K. Taylor et al.

    Genomics

    (1990)
  • D.J. Bradley

    Clin. Exp. Immunol.

    (1977)
  • D.J. Bradley et al.

    Clin. Exp. Immunol.

    (1979)
  • D.J. Bradley et al.

    Trans. Roy. Soc. Trop. Med. Hyg.

    (1972)
  • D.J. Bradley

    Nature

    (1974)
  • J. Plant et al.

    Nature

    (1974)
  • J. Plant et al.

    Clin. Exp. Immunol.

    (1979)
  • J.E. Plant et al.

    Nature

    (1982)
  • B.A. Taylor et al.

    Infect. Immun.

    (1982)
  • E. Skamene et al.

    Nature

    (1982)
  • P. Gros et al.

    J. Immunol.

    (1981)
  • I.N. Brown et al.

    Immunology

    (1982)
  • E. Skamene et al.

    Immunogenetics

    (1984)
  • Y. Goto et al.

    Infect. Immun.

    (1984)
  • A.D. O'Brien et al.

    Nature

    (1980)
  • B.S. Zwilling et al.

    J. Immunol.

    (1987)
  • P.M. Kaye et al.

    Immunology

    (1988)
  • P.E.M. Fine

    Rev. Infect. Dis.

    (1989)
  • J.Y. Channon et al.

    Immunology

    (1984)
  • J.M. Blackwell et al.
  • P.R. Crocker et al.

    Infect. Immun.

    (1984)
  • P.R. Crocker et al.

    Parasite Immunol.

    (1987)
  • D.A. Lepay et al.

    J. Exp. Med.

    (1985)
  • A. Ding et al.

    J. Exp. Med.

    (1988)
  • M. Denis et al.

    Clin. Exp. Immunol.

    (1988)
  • M. Denis et al.

    J. Leuk. Biol.

    (1989)
  • J.M. Blackwell et al.

    Curr. Topics Microbiol. Immunol.

    (1988)
  • D.J. Steuhr et al.
  • Cited by (0)

    View full text